Literature DB >> 9172004

Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats.

A A Bertelli1, L Giovannini, R Stradi, S Urien, J P Tillement, A Bertelli.   

Abstract

Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene), a natural compound from grape products, have been evaluated in rats after oral administration of red wine. Resveratrol concentrations were measured in plasma, heart, liver and kidneys. Tissue concentrations showed a significant cardiac bioavailability and strong affinity for liver and kidneys.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9172004

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN： 0251-1649


  14 in total

1.  Resveratrol-induced gene expression profiles in human prostate cancer cells.

Authors:  Sunita B Jones; Samuel E DePrimo; Michael L Whitfield; James D Brooks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

2.  Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons.

Authors:  S Bastianetto; W H Zheng; R Quirion
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography.

Authors:  David J Boocock; Ketan R Patel; Guy E S Faust; Daniel P Normolle; Timothy H Marczylo; James A Crowell; Dean E Brenner; Tristan D Booth; Andreas Gescher; William P Steward
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-11-09       Impact factor: 3.205

Review 4.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Crystal structure of quinone reductase 2 in complex with resveratrol.

Authors:  Leonid Buryanovskyy; Yue Fu; Molly Boyd; Yuliang Ma; Tze-chen Hsieh; Joseph M Wu; Zhongtao Zhang
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

6.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

7.  Human, rat, and mouse metabolism of resveratrol.

Authors:  Chongwoo Yu; Young Geun Shin; Anita Chow; Yongmei Li; Jerome W Kosmeder; Yong Sup Lee; Wendy H Hirschelman; John M Pezzuto; Rajendra G Mehta; Richard B van Breemen
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

8.  Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

Authors:  S Sale; R D Verschoyle; D Boocock; D J L Jones; N Wilsher; K C Ruparelia; G A Potter; P B Farmer; W P Steward; A J Gescher
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

9.  Resveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulin.

Authors:  Agustin Gonzalez-Vicente; Pablo D Cabral; Jeffrey L Garvin
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

10.  Repressive effects of resveratrol on androgen receptor transcriptional activity.

Authors:  Wen-feng Shi; Melanie Leong; Ellen Cho; Joseph Farrell; Han-chun Chen; Jun Tian; Dianzheng Zhang
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.